Article
The year 2004 has been marked by important developments in IOLs.
Investigators highlight the risk of misdiagnosing geographic atrophy
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb announces launch of new intelligent Arise lens fitting system
FDA approves expanded label for fluocinolone acetonide intravitreal implant
